Brainsway Ltd. is a leading developer of innovative medical devices specialized in non-invasive neuromodulation therapies targeting neurological and psychiatric disorders. Based in Jerusalem, Israel, the company's flagship Deep TMS (Transcranial Magnetic Stimulation) system is recognized for its effectiveness in addressing pressing unmet medical needs worldwide. With a robust focus on research and development, Brainsway aims to improve patient outcomes while positioning itself as a key player in the expanding neuromodulation market. The company’s strategic endeavors to broaden clinical applications and enhance its product portfolio are poised to drive significant growth within the dynamic healthcare sector. Show more

Location: 16 HARTUM ST, JERUSALEM, ISRAEL, 9777516, Jerusalem, 9777516, USA | Website: https://www.brainsway.com | Industry: MEDICAL DEVICES | Sector: HEALTHCARE


Market Cap

414.8M

52 Wk Range

$7.84 - $25.65

Previous Close

$20.93

Open

$21.29

Volume

32,016

Day Range

$20.96 - $21.95

Enterprise Value

369M

Cash

70.46M

Avg Qtr Burn

N/A

Insider Ownership

6.17%

Institutional Own.

31.18%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date